This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
These drugs, known as GLP-1s, are contributing to a significant spike in pharmaceutical costs and adding to overall health care outlays. increase in healthinsurance costs, even after implementing cost-reduction measures. The full list price for Ozempic was $969 in the fall, down 9.7%
This strain forces public sector entities to make difficult decisions in regard to benefit design, cost-sharing and overall plan affordability. In the struggle to balance fiscal responsibility and competitive benefitpackages, its often the employee benefit programs and services that lose ground.
Offering an attractive employee benefitspackage helps lure top talent and encourages the retention of your best team members. Presenting a good employee benefitspackage often gives one employer an edge over another, especially in cases where basic salaries are relatively equal. There’s no one-size-fits-all answer.
These drugs, known as GLP-1s, are contributing to a significant spike in pharmaceutical costs and adding to overall health care outlays. increase in healthinsurance costs, even after implementing cost-reduction measures. The full list price for Ozempic was $969 in the fall, down 9.7%
It’s almost time for year-end small group open enrollment and you need to drive engagement so that your employees can make informed decisions about their healthinsurance options. Engage employees and solicit feedback through quarterly employee-benefits round table meetings.
We organize all of the trending information in your field so you don't have to. Join 46,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content